Federal Circuit confirms Biogen’s multi-billion dollar Tecfidera patent disaster
In a split decision, the CAFC has upheld a decision that cut short the exclusivity of the company’s best-selling product by eight years
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.